Zewei Shen

Novo Nordisk (China) Pharmaceuticals

SCHOLARLY PAPERS

1

DOWNLOADS

168

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Prevalence of Obesity and Associated Complications in China: A Nationwide, Cross-Sectional, Observational, Real-World Study in 15.8 Million Adults

Number of pages: 40 Posted: 14 Dec 2022
Government of the People's Republic of China - Department of Endocrinology, Novo Nordisk (China) Pharmaceuticals, Government of the People's Republic of China - Department of Endocrinology, Government of the People's Republic of China - Department of Endocrinology, Novo Nordisk (China) Pharmaceuticals, Government of the People's Republic of China - Department of Endocrinology and Novo Nordisk (China) Pharmaceuticals
Downloads 168 (330,311)

Abstract:

Loading...

Obesity, Overweight, China, Prevalence, weight-related complications